diff --git "a/38eb2591-663b-40cf-9114-22622baf57c1.json" "b/38eb2591-663b-40cf-9114-22622baf57c1.json" new file mode 100644--- /dev/null +++ "b/38eb2591-663b-40cf-9114-22622baf57c1.json" @@ -0,0 +1,40 @@ +{ + "interaction_id": "38eb2591-663b-40cf-9114-22622baf57c1", + "search_results": [ + { + "page_name": "Investor FAQs | Regeneron Pharmaceuticals Inc.", + "page_url": "https://investor.regeneron.com/investor-faqs", + "page_snippet": "You can purchase stock in our company through a registered brokerage or stock purchase service provider of your choice. You cannot buy Regeneron stock directly from the company. You will need to contact the broker from whom you purchased your shares.You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website. The most up-to-date number of shares outstanding can be found on the front page of our most recent form 10-Q, which can be found at the Financial Information section on our Investor Relations website. You can purchase stock in our company through a registered brokerage or stock purchase service provider of your choice. You cannot buy Regeneron stock directly from the company. You can purchase stock in our company through a registered brokerage or stock purchase service provider of your choice. You cannot buy Regeneron stock directly from the company. You will need to contact the broker from whom you purchased your shares. Shares of our common stock are listed on The NASDAQ Global Select Market under the symbol REGN. The most up-to-date number of shares outstanding can be found on the front page of our most recent form 10-Q, which can be found at the Financial Information section on our Investor Relations website.", + "page_result": "\n\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Investor FAQs | Regeneron Pharmaceuticals Inc.\n \n\n\n\n\n\n\n\n\n \n\n\n \r\n\r\n\r\n\r\n\n \n \n \n
\n \n\n
\n\n
\n
\n
\n
\n \n \n\n
\n
\n
\n
\n \n
\n
\n
\n \n
\n
\n
\n
\n
\n\n\n
\n
\n
\n
\n
\n

INVESTORS & MEDIA

\n\n

Investor FAQs

\n
\n\n
\n
\n
\n\n\n
\n\n \n
\n
\n
\n
\n\n
\n
\n
\n
\n \n \n \n
\n
\n
\n \n \n
\n
\n \n
\n\n
\n
\n
\n
\n
\n \n \n
\n
\n
\n
\n\n \n \n\n
\n \n
\n \n
\n\n

We started trading publicly in April 1991.

\n
\n \n
\n\n

Our corporate headquarters and research laboratories are located in Tarrytown, NY, our large-scale manufacturing facilities are located in Rensselaer, NY and Limerick, Ireland, our satellite offices are located in Sleepy Hollow, NY and Basking Ridge, NJ, and our European business offices are located in Dublin, Ireland and London, United Kingdom.

\n
\n \n
\n\n

As of December 2020, we have over 9,000 regular employees.

\n
\n \n
\n\n

Shares of our common stock are listed on The NASDAQ Global Select Market under the symbol REGN.

\n
\n \n
\n\n

The most up-to-date number of shares outstanding can be found on the front page of our most recent form 10-Q, which can be found at the Financial Information section on our Investor Relations website.

\n
\n \n
\n\n

You can purchase stock in our company through a registered brokerage or stock purchase service provider of your choice. You cannot buy Regeneron stock directly from the company.

\n
\n \n
\n\n

You will need to contact the broker from whom you purchased your shares.

\n
\n \n
\n\n

American Stock Transfer & Trust
\n6201 15th Avenue
\nBrooklyn, New York 11219
\n(800) 937-5449

\n
\n \n
\n\n

No, we have never paid a cash dividend nor do we expect to pay any dividends in the foreseeable future.

\n
\n \n
\n\n

We typically report quarterly financial results and hold a related conference call around 40 days after the final day of the quarter. You can access our earnings press releases in the News section, and the Earnings Call webcasts in the Events section of our Investor Relations website.

\n
\n \n
\n\n

Our Annual Meeting of Stockholders is held each June in Tarrytown, New York.\u00a0An announcement with exact date, time and location will be posted on our website at least 70 days before the event each year.

\n
\n \n
\n\n

Proxy statements are available through the Financial Information section of our Investor Relations website under the heading \"SEC Filings.\"

\n
\n \n
\n\n

PricewaterhouseCoopers LLC

\n
\n \n
\n\n

If you can't find the information you're looking for on our Web site, please feel free to contact Investor Relations at (914) 847-7741.\u00a0

\n
\n \n
\n\n

Please visit the Financial Information\u00a0section\u00a0of the Investor Relations\u00a0website\u00a0or refer to the most recent 10-Q or 10-K report under the heading \"SEC Filings.\"

\n
\n \n
\n\n

Please visit the Investor Relations website and choose the \"Email Alerts\" tab to be added to the Regeneron distribution list.

\n
\n\n\n\n \n
\n\n
\n
\n \n
\n
\n \n
\n
\n
\n
\n
\n
\n
\n
\n
\n\n
\n\n
\n
\n\n
\n\n
\n\n\n
\n
\n \n\n\n \n\n
\n \n\n \n \n
\n\n \n \n \n \n \n \n \n \n \n
\n \n\n\n \n
\n \n
\n
\n
\n
\n
\n
\n\n \n\n\n\n\n\n\n\n
\n
\n
\n
\n

Investors & Media

\n
\n
\n
\n
\n \n \n
\n \n
\n
\n
\n
\n
\n\n
\n
\n\n
\n
\n
\n

You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

\n
\n Continue\n
\n \n
\n
\n
\n\n\n\n
\n
\n
\n

You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

\n
\n Continue\n
\n \n
\n
\n
\n
\n\n \n \n \n\n\n\n\n\n\n \n \n\n", + "page_last_modified": " Wed, 28 Feb 2024 14:59:02 GMT" + }, + { + "page_name": "Buy shares of Regeneron Pharmaceuticals Inc stock (REGN)", + "page_url": "https://www.stash.com/investments/stocks/regeneron-pharmaceuticals-inc-regn/", + "page_snippet": "You can buy Regeneron Pharmaceuticals Inc (REGN) stock and many other stocks or ETFs on Stash. Purchase fractional shares with any dollar amount.Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. ... Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.of Regeneron Pharmaceuticals Inc stock, you'll need to sign up for Stash and open a personal portfolio. Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. Regeneron Pharmaceuticals Inc\u2019s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Regeneron Pharmaceuticals Inc\u2019s price can fluctuate throughout the course of each trading day\u2014when you buy Regeneron Pharmaceuticals Inc through Stash, we execute the market order during our next available trading window (we have two a day). Regeneron Pharmaceuticals Inc\u2019s price can fluctuate throughout the course of each trading day\u2014when you buy Regeneron Pharmaceuticals Inc through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don\u2019t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them. Use our historic performance chart to see real-time Regeneron Pharmaceuticals Inc stock price and the Regeneron Pharmaceuticals Inc news feed to help further your research before investing in fractional shares with any dollar amount you choose.", + "page_result": "Buy Regeneron Pharmaceuticals Inc stock (REGN) | Stash
Skip Navigation
Stash
Sign\u00a0up

Browse investments

Invest in Regeneron Pharmaceuticals Inc on Stash

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.

To buy fractional shares

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.
of Regeneron Pharmaceuticals Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you\u2019ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

\"Regeneron

Ticker: REGN

Regeneron Pharmaceuticals Inc

$993.35

+4.78%

(1W)

$

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Historical performance data are provided \u201cas is\u201d and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). \u00a92024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

REGN Performance Breakdown

Share Price

The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).\n

$993.35

Today's change

This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.

0.0%

Year to date change (YTD)

This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).\n

9.76%

Dividend yield

Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.

N/A

Last dividend paid

The dollar value per share that was paid out to shareholders.

N/A

Last dividend pay date

The date shareholders were paid out for the last dividend issued.

N/A

About REGN

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Regeneron Pharmaceuticals Inc Stock Ticker

REGN

For more information

https://investor.regeneron.com/investor-relations

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Historical performance data are provided \u201cas is\u201d and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by Thomson Reuters (Refinitiv). \u00a92024 Thomson Reuters. Stash cannot and does not represent or guarantee that any of the information available via Refinitiv is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Invest in Regeneron Pharmaceuticals Inc on Stash

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.

To buy fractional shares

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.
of Regeneron Pharmaceuticals Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you\u2019ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Certain companies are volatile.

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don\u2019t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Regeneron Pharmaceuticals Inc stock news

This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.

CNBC
TJX tops earnings estimates as holiday sales jump 13%

Off-price giant TJX Companies, which runs TJ Maxx, Marshall's and Homegoods, saw sales rise 13% during its holiday quarter.

about 1 hour ago

24/7 Wall Street
Don't Get Near These 10%+ Dividend Yield Stocks

URGENT \u2013 New Seats Available (sponsored) Top financial advisors are now accepting new clients for 2024!

24 minutes ago

Business Insider
Google chief says the company got it wrong after Gemini gave 'completely unacceptable' responses and sparked a bitter backlash

Google CEO Sundar Pichai says the company got it wrong as controversy swirls over its Gemini AI. Pichai made the comments in a memo sent to staff and obtained by Business Insider.

about 2 hours ago

CNBC
AirAsia unit heads for U.S. listing through SPAC deal as CEO says 'Americans understand branding'

AirAsia CEO Tony Fernandes told CNBC that U.S. investors have a better understanding of branding opportunities.

about 3 hours ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.\u2020

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,8 recurring investments, and more.

The Stock-Back\u00ae Card

We\u2019ll give you matching stock in companies you shop at.1

Learn how to invest

Get professional advice and education at every step.

How to buy Regeneron Pharmaceuticals Inc stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Regeneron Pharmaceuticals Inc\u2019s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Regeneron Pharmaceuticals Inc\u2019s price can fluctuate throughout the course of each trading day\u2014when you buy Regeneron Pharmaceuticals Inc through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don\u2019t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Regeneron Pharmaceuticals Inc stock price and the Regeneron Pharmaceuticals Inc news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers two subscription plans: Stash Growth and Stash+.

Each plan can help you reach different goals and offers a unique combination of financial accounts and features. All plans include access to a personal brokerage account\u2014also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Regeneron Pharmaceuticals Inc stock is complete, you'll officially be a shareholder of Regeneron Pharmaceuticals Inc!

You can continue to build your portfolio by buying more stocks and funds\u2014there are hundreds of options on Stash.

Invest in Regeneron Pharmaceuticals Inc on Stash

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.

To buy fractional shares

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.
of Regeneron Pharmaceuticals Inc stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you\u2019ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Stash resources for confident investing

\"How

How to Start Investing: A Comprehensive Guide for Beginners

\"What

What Are Fractional Shares?

\"How

How To Read a Stock Chart: A Beginner\u2019s Guide + Stock Chart Glossary

They tell the story of your investment over time

Subscribe to The Wallet!

Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!

By using this website you agree to our Terms of Use and Privacy Policy.

Ready to start
building wealth?

By using this website you agree to our Terms of Use and Privacy Policy.

\"Google\"App
InstagramTwitterLinkedIn5967A220-6EC0-46D6-8A99-1222576A842ACreated with sketchtool.FacebookYouTube

Legal\u00a0\u00a0|\u00a0\u00a0Privacy Policy

  • \u2020Stash offers access to investment and banking accounts under each subscription plan. Each type of account is subject to different regulations and limitations. Subscription fee starts at $3/month. You\u2019ll also bear standard fees and expenses reflected in the pricing of the ETFs, plus fees for various ancillary services charged by Stash and the Custodian. Please see Advisory Agreement for details. Other fees apply to the bank account. Please see Deposit Account Agreement for details.
  • \u00a7 Depending on the subscription plan, there may be additional steps a user must take to cancel their account which may impact the amount of time it takes to fully close an account.

  • \u2021 Group life insurance coverage provided through Avibra, Inc. Stash is a paid partner of Avibra. Only individuals ages 18-54 and who are residents of one of the 50 U.S. states or DC are eligible for group life insurance coverage, subject to availability. Individuals with certain pre-existing medical conditions may not be eligible for the full coverage above, but may instead receive less coverage. All insurance products are subject to state availability, issue limitations and contractual terms and conditions, any of which may change at any time and without notice. Please see Terms and Conditions for full details. Stash may receive compensation from business partners in connection with certain promotions in which Stash refers clients to such partners for the purchase of non-investment consumer products or services. Clients are, however, not required to purchase the products and services Stash promotes.

  1. Stash Banking services provided by Stride Bank, N.A., Member FDIC. The Stash Stock-Back\u00ae Debit Mastercard\u00ae is issued by Stride Bank pursuant to license from Mastercard International. Mastercard and the circles design are registered trademarks of Mastercard International Incorporated. Any earned stock rewards will be held in your Stash Invest account. Investment products and services provided by Stash Investments LLC, not Stride Bank, and are Not FDIC Insured, Not Bank Guaranteed, and May Lose Value. In order for a user to be eligible for a Stash banking account, they must also have opened a taxable brokerage account on Stash.

    All rewards earned through use of the Stash Stock-Back\u00ae Debit Mastercard\u00ae will be fulfilled by Stash Investments LLC. You will bear the standard fees and expenses reflected in the pricing of the investments that you earn, plus fees for various ancillary services charged by Stash. In order to earn stock in the program, the Stash Stock-Back\u00ae Debit Mastercard must be used to make a qualifying purchase. What doesn\u2019t count: Cash withdrawals, money orders, prepaid cards, and P2P payment. If you make a qualifying purchase at a merchant that is not publicly traded or otherwise available on Stash, you will receive a stock reward in an ETF or other investment of your choice from a list of companies available on Stash. 1% Stock-Back\u00ae rewards are subject to terms and conditions. Stock rewards that are paid to participating customers via the Stash Stock Back program, are Not FDIC Insured, Not Bank Guaranteed, and May Lose Value. Stash reserves the right to amend this program and the terms and conditions thereof and/or cancel this program at any time, for any reason, upon notice to you. See Terms and Conditions for more details.

  2. Get fee-free transactions at any Allpoint ATM, see the app for location details, otherwise out-of-network ATM fees may apply. For a complete list of fees please see the Deposit Account Agreement for details.
  3. Early access to direct deposit funds depends on when the payor sends the payment file. We generally make these funds available on the day the payment file is received, which may be up to 2 days earlier than the scheduled payment date.
  4. Stash does not monitor whether a customer is eligible for a particular type of IRA, or a tax deduction, or if a reduced contribution limit applies to a customer. These are based on a customer\u2019s individual circumstances. You should consult with a tax advisor.
  5. The money in a custodial account is the property of the minor.
  6. Not all stocks pay out dividends.
  7. This is a Discretionary Managed Account whereby Stash has full authority to manage. Diversification and asset allocation do not guarantee a profit, nor do they eliminate the risk of loss of principal. Stash does not guarantee any level of performance or that any client will avoid losses in the client\u2019s account.
  8. A \u201cPersonal Portfolio\u201d is a non-Discretionary Managed Account.
  9. Stash through the \u201cDiversification Analysis\u201d feature does not rebalance portfolios or otherwise manage the Personal Portfolio Account for clients on a discretionary basis. Recommendations through this tool are considered personalized investment advice. No asset allocation is a guarantee against loss of principal.
  10. To be eligible to receive a Stock Reward through stock party, you must complete the account registration process and open an individual taxable brokerage account (\"Personal Portfolio\") that is in good standing. This program is subject to Terms and Conditions.
  11. If you purchase this plan, you will receive Financial Counseling Advice which is impersonal investment advice, as guides, reports, and education material about investing and financial planning. Each plan includes the option to open a brokerage account and a bank account. The subscription fee is due if a client is receiving Financial Counseling Services regardless of whether or not a client chooses to open and/or use a brokerage account. In order to obtain personalized investment advice, clients are required to complete the suitability questionnaire during registration, must be approved from an account verification perspective and open a brokerage account. Click here for more details.
  12. You may subsequently choose to open one or more investment advisory account(s). To begin investing on Stash, you must be approved from an account verification perspective and open a brokerage account.
  13. This Program is subject to terms and conditions. In order to participate, a user must comply with all eligibility requirements and make a qualifying purchase with their Stock-Back\u00ae Card. All funds used for this Program will be taken from your Stash Banking account\u2020.
  14. Unpaid client testimonials. Not representative of all clients and not a guarantee. See Apple App Store and Google Play reviews. Immaterial changes have been made to these quotes for editorial purposes.
  15. Based on comparative data on debit cards in the U.S that offer stock rewards when used to shop at publicly traded companies.
  • Nothing on this website should be considered an offer, solicitation of an offer, tax, legal, or investment advice to buy or sell securities. Any historical returns, expected returns or probability projections are hypothetical in nature and may not reflect actual future performance. Account holdings are for illustrative purposes only and are not investment recommendations. All investments are subject to risk and may lose value. If applicable, your Stash banking account is a funding account for purposes of the Advisory Agreement. Your subscription fee may be deducted from your Stash banking account balance.
  • By clicking on any third-party links above, you will leave Stash\u2019s website and link to a non-affiliated third-party website. The privacy practices of those third parties may differ from those of Stash. Therefore, we recommend you review the privacy statements of those third-party websites, as Stash is not responsible for those third parties' privacy or security practices.
  • All individuals featured on this website are paid actors or employees of Stash.
  • By using this website, you understand the information being presented is provided for informational purposes only and agree to our Terms of Use and Privacy Policy. Stash does not provide comprehensive financial planning services to individual investors. Stash Financial, Inc. is a digital financial services company offering financial products for U.S. based consumers. Stash is not a bank or depository institution licensed in any jurisdiction Advisory products and services are offered through Stash Investments LLC (\u201cStash\u201d), an SEC registered investment adviser. Stash Capital LLC, an SEC registered broker-dealer and member FINRA/SIPC, serves as introducing broker for Stash Clients\u2019 advisory accounts. FINRA BrokerCheck reports for Apex Clearing are available at https://brokercheck.finra.org/. Apex Clearing Corporation, a third-party SEC registered broker-dealer and member FINRA/SIPC, provides clearing and execution services and serves as qualified custodian for advisory assets of Stash Clients. Products offered by Stash Investments LLC and Stash Capital LLC are Not FDIC Insured, Not Bank Guaranteed, and May Lose Value. Market data by Thomson Reuters (Refinitiv).
  • For more information, see our disclosures.
  • All product and company names are trademarks\u2122 or registered\u00ae trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.
  • Stash supports an accessible internet. If you have any questions about our features, please contact us at accessibility@stash.com. Information provided by Stash Support is for informational and general educational purposes only and is not investment or financial advice.
  • Email: support@stash.com Tel: (800) 205-5164
    Google Play and the Google Play logo are trademarks of Google, Inc.
    Apple, the Apple logo, and iPhone are trademarks of Apple, Inc., registered in the U.S.
    STASH, StashInvest, and Stock-Back are registered trademarks of Stash Financial, Inc.
    \u00a9 Copyright 2023 Stash Financial, Inc. All rights reserved.
", + "page_last_modified": " Wed, 28 Feb 2024 14:32:29 GMT" + }, + { + "page_name": "Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Stock Price, ...", + "page_url": "https://www.nasdaq.com/market-activity/stocks/regn", + "page_snippet": "Discover real-time Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.**Green highlights the top performing ETF by % change in the past 100 days.", + "page_result": "\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n
\n\n \n \n\n \n \n \n \n \n \n \n\n \n \n \n \n\nSkip to main content\n\n
\n \n
\n\n
\n \n \n \n\n
\n \n
\n\n \n\n\n\n\n\n\n\n\n\n\n\n \n
\n\n
\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n
\n\n\n\n
\n
\n
\n
\n
\n\n\n \n\n \n \n
\n
\n
\n
\n \n
\n
\n
\n
\n
\n
\n \n \n
\n
\n\n\n
\n
\n \n \n
\n
\n\n\n
\n \n
\n
\n \n
\n \n \n\n
\n \n
\n \n When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.\n
\n
\n
\n\n
\n
\n \n \n
\n
\n\n\n
\n
\n \n \n
\n
\n\n\n
\n
\n\n
\n
\n
\n
\n\n\n\n
\n\n\n\n\n
\n
\n
\n \n
\n
\n
\n
\n
\n
\n\n
\n

\n Regeneron Pharmaceuticals, Inc. Common Stock (REGN)\n

\n\n
\n \n
\n
\n\n
\n\n
\n
\n \n \n \n
\n \n \n \n
\n
\n \n
\n \n
\n
\n\n
\n
\n \n\n\n\n
\n
\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
\n
\n\n\n
Data is currently not available
\n \n
\n\n\n
\n \n \n \n
\n \n \n \n
\n
\n Bid:\n \n \n x \n \n
\n Ask:\n \n \n x \n \n
\n
\n Volume:\n \n
\n
\n \n
\n \n
\n
\n\n \n
\n
\n\n \n \n
\n
\n
\n \n
\n
\n
\n
\n
\n
\n \n \n \n \n \n
    \n     \n
    \n\n
    \n
    \n \n
    \n
    \n \n
    \n
    \n\n
    \n\n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n
    \n
    \n
    \n\n\n\n
    \n\n\n
    \n
    \n
    \n
    \n \n
    \n

    Quotes

    \n \n
    \n
    \n

    NEWS & ANALYSIS

    \n \n
    \n \n
    \n \n
    \n\n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n\n\n
    \n\n
    \n
    \n
    \n \n \n
    \n\n
    \n\n
    \n
    \n\n
    \n \n
    \n\n
    \n \n
    \n
    \n
    \n \n
    \n \n \n \n \n \n \n \n \n \n
    \n \n
    \n
    \n\n\n
    \n
    \n\n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n Previous
    Close    \n  \n
    \n
    \n\n \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n
    \n
    \n\n
    \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n\n
    \n
    \n
    \n
    \n
    \n

    \n Key Data\n

    \n\n\n
    \n\n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n \n \n \n \n \n \n \n \n \n \n \n \n
    LabelValue
    \n
    \n \n\n
    \n\n \n

    \n Bid Price and Ask Price\n

    \n \n
    \n \n \n \n

    \n The\u202fbid\u202f&\u202fask\u202frefers to the price that an investor is willing to buy or sell a stock. The\u202fbid\u202fis the highest amount that a buyer is currently willing to pay, whereas the ask\u202fis the lowest\n \n amount that a seller is currently willing to sell. The numbers next to the bid/ask are the \u201csize\u201d. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time.

    \r\n\r\nThe\u202fbid-ask spread\u202fcan indicate a stock\u2019s liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. You can use the bid-ask spread to determine whether to place a\u202f market order\u202for\u202flimit order\u202fwhen trading, helping you to optimize your price and have a successful order execution.

    \r\n\r\nReal-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visit\u202fNasdaq Data Link's products page.    \n \n

    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n
    LabelValue
    \n
    \n
    \n Powered by Nasdaq Data Link \n
    \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n\n\n
    \n\n\n
    \n \n
    \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \r\n\n
    \n
    \n
    \n
    \n
    \n
    \n \n
    \n
    \n
    \n
    \n\n
    \n
    \n
    \n

    Analyze your stocks, your way

    \n
    \n

    Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.

    \n
    \n
    \n \n Subscribe Now ->\n \n
    \n
    \n
    \n
    \n
    \n\n\n
    \n
    \n
    \n \n
    \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n
    \n
    \n\n
    \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
    \n \n
    \n
    \n

    *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

     \n

    **Green highlights the top performing ETF by % change in the past 100 days.

    \n
    \n
    \n
    \n
    \n\n\n\n\n
    \n
    \n
    \n
    \n\n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n

    \n News\n

    \n\n\n
    \n
    \n
    \n
    \n \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n \n See All News\n \n \n
    \n
    \n\n \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n

    About

    \n
    \n
    \n
    \n
    \n \n \n \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    Key Executives
    \n \n \n \n \n \n \n \n \n \n
    NameTitle
    \n
    \n \n
    \n \n
    \n\n\n\n\n
    \n
    \n
    \n

    \n Trending\n

    \n\n\n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n
    \n \n \n \n \n \n

    \n
    \n \n \n \n \n
    \n
    \n\n\n
    \n
    \n
    \n\n
    \n\n
    \n\n\n
    \n
    \n \n
    \n
    \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n \r\n
    \r\n \n
    \n
    \n\n
    \n
    \n
    \n
    • Real-time Data is provided using Nasdaq Last Sale Data
      • \n

    \u00a0

    \n\n

    Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at\u00a0data.nasdaq.com.

    \n\n
    \n
    \n
    \n\n\n\n\n
    \n\n \n
    \n\n \n \n
    \n \n\n
    \n \n
    \n
    \n \n
    \n
    \n
    \n
    \n \n View as Table\n
    \n
    \n
    now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.
    \n
    \n
    \n
    \n \n\n
    \n
    \n \n\n\n\n\n\n \n\n\n
    \n\n
    \n /\n
    \n\n
    \">\n \n\n\n\n\n\n \n\n\n
    \n
    \n\n\n
    \n \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n \n Edit Watchlist\n
    \n
    \n
    \n Your Watchlist is empty.\n \n
    \n
    \n
    \n
    Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.
    \n
    \n
    \n
    \n \n\n
    \n
    \n \n\n\n\n\n\n \n\n\n
    \n\n
    \n /\n
    \n\n
    \">\n \n\n\n\n\n\n \n\n\n
    \n
    \n\n\n
    \n
      \n
    • \n \n \n \n

      \n

      \n \n \n

      \n       \n
      \n
      • \n
      \n
      \n
      \n \n \n
      \n
      \n\n\n\n
      \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Go to Smart Portfolio\n
    \n
    \n
    \n
    \n
    \n
    \n\n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    \n
    \n
    \n\n
    \n
    \n
    \n \n \n
    \n\n
    \n \n
    \n \n
    \n
    \n\n
    \n \n \n
    \n\n
    \n
    Most Active
    \n
      \n
    • \n \n \n \n
      • \n\n
      \n \n\n\n\n
      \n
      \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
      \n
      \n\n\n
      \n
      \n
      \n
      \n\n
      \n\n \n\n\n\n\n \n\n\n\n\n \n\n\n\n \n\n\n\n\n\n\n \n
      \n
      \n\n\n\n\n\n\n\n\n\n\n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n\n \n\n\n", + "page_last_modified": "" + }, + { + "page_name": "REGN | Regeneron Pharmaceuticals Inc. Stock Price & News - WSJ", + "page_url": "https://www.wsj.com/market-data/quotes/REGN", + "page_snippet": "", + "page_result": "\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n REGN | Regeneron Pharmaceuticals Inc. Stock Price & News - WSJ\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n if (window.__ace && typeof window.__ace === 'function') {\n const id = '61f2bdf7b00575078c959fee';\n const cb = () => {\n const vendorScript = document.createElement('script');\n vendorScript.src = 'https://d3icekm41k795y.cloudfront.net/rsxvmxxqlm.js';\n vendorScript.setAttribute('id', 'adtoniq');\n vendorScript.async = true;\n vendorScript.addEventListener('load', function () { window.__ace('page', 'setPerfMark', ['adtoniq-loaded']);window.__ace('adtoniq', 'initListener', ['154a3e38-2228-44d6-9db6-c9707f3647ea']); });\n document.body.appendChild(vendorScript);\n }\n __ace('djcmp', 'executeOnCmpReady', [{cb, id }]);\n };\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
      \n \n
      \n

      The Wall Street Journal

      English Edition
      More

      \n
      \n \n \n \n
      View All Companies

      Regeneron Pharmaceuticals Inc.

      REGN (U.S.: Nasdaq)
      Overview
      Profile
      Financials
      Income Statement
      Balance Sheet
      Cash Flow
      Research & Ratings
      Historical Prices
      Options
      Advanced Charting

      NewsRegeneron Pharmaceuticals Inc.REGN

      No significant news for in the past two years.
      Key Stock Data
      P/E Ratio (TTM)
      The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
      Earnings Per Share (TTM)
      A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
      Market Capitalization
      Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
      Shares Outstanding
      Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
      Public Float
      The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
      Dividend Yield
      A company's dividend expressed as a percentage of its current stock price.

      Key Stock Data

      • P/E Ratio (TTM)
        28.73(02/28/24)
      • EPS (TTM)
        $34.75
      • Market Cap
        $108.59 B
      • Shares Outstanding
        107.94 M
      • Public Float
        105.06 M
      • Yield
        REGN is not currently paying a regular dividend.
      • Latest Dividend
        N/A
      • Ex-Dividend Date
        N/A
      Shares Sold Short
      The total number of shares of a security that have been sold short and not yet repurchased.
      Change from Last
      Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
      Percent of Float
      Total short positions relative to the number of shares available to trade.

      Short Interest (02/15/24)

      • Shares Sold Short
        1.37 M
      • Change from Last
        9.61%
      • Percent of Float
        1.30%
      Money Flow Uptick/Downtick Ratio
      Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

      Stock Money Flow

      • N/A

      Research & Ratings Regeneron Pharmaceuticals Inc.(REGN)

      Per-Share Earnings, Actuals and Estimates

      REGN will report Q1 earnings on 05/02/2024
      Actual Analyst Range Consensus
      14.00
      12.00
      10.00
      8.00
      Actual10.09
      9.52
      Actual10.24
      9.85
      Actual11.59
      10.68
      Actual11.86
      10.73
      10.04
      11.12
      Q12023Q2Q3Q4Q12024Q2
      Q1 2024 Estimate Trends
      Current:$10.04
      1 month ago:$10.60
      3 months ago:$10.62
      Q2 2024 Estimate Trends
      Current:$11.12
      1 month ago:$11.39
      3 months ago:$11.64

      Financials Regeneron Pharmaceuticals Inc.(REGN)

      Net Income

      0
      400M
      800M
      1.2B
      1.6B
      Jan1Jan1Jan1Jan1Jan1
      Jan 00015-quarter trend
      Net Income Growth-3.13%
      Sales or Revenue3.36 B
      Sales or Revenue Growth+0.58%
      EBITDA-
      \n
      \n \n \n \n
      Overview
      \n

      Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019\u00a9 FactSet Research Systems Inc. All rights reserved. Source: FactSet

      \n

      Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

      \n

      Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

      \n

      Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

      \n

      ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

      \n

      Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

      \n

      Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

      \n

      Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

      \n \n

      Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

      \n

      Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019\u00a9 Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

      \n

      Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

      \n

      Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media

      \n
      \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n\n\n \n \n ", + "page_last_modified": "" + }, + { + "page_name": "Stock Information | Regeneron Pharmaceuticals Inc.", + "page_url": "https://investor.regeneron.com/stock-information", + "page_snippet": "The Investor Relations website contains information about Regeneron Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website. You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.", + "page_result": "\n\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Stock Information | Regeneron Pharmaceuticals Inc.\n \n\n\n\n\n\n\n\n\n \n\n\n \r\n\r\n\r\n\r\n\n \n \n \n
      \n \n\n
      \n\n
      \n
      \n
      \n
      \n \n \n\n
      \n
      \n
      \n
      \n \n
      \n
      \n
      \n \n
      \n
      \n
      \n
      \n
      \n\n\n
      \n
      \n
      \n
      \n
      \n

      INVESTORS & MEDIA

      \n\n

      Stock Information

      \n
      \n\n
      \n \n\n \n \n\n
      \n \n
      \n
      \n\n \n
      \n Stock Information\n
      \n \n
      \n Historic Price Lookup\n
      \n \n
      \n Investment Calculator\n
      \n \n
      \n Ownership Profile\n
      \n
      \n\n
      \n \n\n\n
      \n \n
      \n
      \n
      \n
      \n\n\n
      \n\n \n
      \n
      \n
      \n
      \n\n
      \n
      \n
      \n
      \n \n \n \n
      \n
      \n
      \n \n \n
      \n
      \n \n
      \n\n
      \n
      \n
      \n
      \n
      \n \n

      Stock Quote

      \n \n \n
      \n
      \n\n
      \n
      \n
      \n\n
      :
      \n\n
      \n\n
      \n\n
      \n
      \n (%)\n
      \n Change (%)\n
      \n\n
      Today's high
      \n\n
      Today's open
      \n\n\n
      52-week high
      \n
      \n
      \n
      Volume\n
      \n\n
      Today's low
      \n\n
      Previous close
      \n\n
      52-week low
      \n
      \n\n

      \n 02/14/24 9:35 AM EST\n

      \n
      \n\n
      \n
      \n
      \n
      \n
      \n
      \n \n

      Stock Chart

      \n \n \n\n\n
      \n
      \n \n \n

      \n Data Provided by Refinitiv. Minimum 15 minutes delayed.

      \n\n
      \n
      \n
      \n
      \n
      \n
      \n\n
      \n\n
      \n
      \n\n
      \n\n
      \n\n\n
      \n
      \n \n\n\n \n\n
      \n \n\n \n \n
      \n\n \n \n \n \n \n \n \n \n \n
      \n \n\n\n \n
      \n \n
      \n
      \n
      \n
      \n
      \n
      \n\n \n\n\n\n\n\n\n\n
      \n
      \n
      \n
      \n

      Investors & Media

      \n
      \n
      \n
      \n
      \n \n \n
      \n \n
      \n
      \n
      \n
      \n
      \n\n
      \n
      \n\n
      \n
      \n
      \n

      You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

      \n
      \n Continue\n
      \n \n
      \n
      \n
      \n\n\n\n
      \n
      \n
      \n

      You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

      \n
      \n Continue\n
      \n \n
      \n
      \n
      \n
      \n\n \n \n \n\n\n\n\n\n\n \n \n\n", + "page_last_modified": " Wed, 28 Feb 2024 15:23:44 GMT" + } + ] +} \ No newline at end of file